Sponsor Pipeline

Kong Fanming Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 2/3
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07034326 Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After… Non-Small Cell Lung Cancer Recruiting
Not specified
NCT07086300 Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC Elderly Patients (>65 Years) Recruiting
NCT06548711 Effect of Transcutaneous Acupoint Electrical Stimulation (TAES) on Postoperative Cough in… Postoperative Cough Recruiting
NCT07239661 Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC Non-Small Cell Lung Cancer Recruiting
Disease Areas
Get alerts when Kong Fanming's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free